XML 66 R50.htm IDEA: XBRL DOCUMENT v3.3.1.900
STOCK-BASED COMPENSATION PLANS (Details)
12 Months Ended
Dec. 31, 2015
USD ($)
Plan
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Dec. 31, 2013
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of compensation plans | Plan 3    
Shares available for grant under 2014 LTIP Plan (in shares) 1,083,834    
Weighted-Average Exercise Price [Roll Forward]      
Intrinsic value of exercised options and stock-settled appreciation rights | $ $ 457,000 $ 184,000 $ 1,312,000
Total compensation cost related to unvested equity awards | $ $ 4,509,000    
Weighted-average period of recognition of cost 2 years 2 months 12 days    
Restricted Stock Award [Member]      
Shares or Units and Rights [Roll Forward]      
Outstanding, beginning balance (in shares) 321,322 437,000 555,925
Granted (in shares) 176,135 146,748 162,150
Exercised or restrictions lapsed (in shares) [1] (147,595) (235,925) (277,975)
Forfeited or expired (in shares) (5,372) (26,501) (3,100)
Restricted units expected to vest (in shares) 344,490    
Outstanding, ending balance (in shares) 344,490 321,322 437,000
Weighted-Average Award Price [Roll Forward]      
Outstanding, beginning balance (in dollars per share) | $ / shares $ 20.49 $ 14.46 $ 12.28
Granted (in dollars per share) | $ / shares 23.97 28.72 18.15
Exercised or restrictions lapsed (in dollars per share) | $ / shares [1] 18.94 14.01 12.24
Forfeited or expired (in dollars per share) | $ / shares 24.84 24.28 15.00
Restricted units expected to vest (in dollars per share) | $ / shares 22.87    
Outstanding, ending balance (in dollars per share) | $ / shares $ 22.87 $ 20.49 $ 14.46
Weighted-Average Exercise Price [Roll Forward]      
Aggregate intrinsic value of outstanding awards | $ $ 7,386,000    
Fair value of vested restricted common stock | $ $ 3,097,000 $ 5,985,000 $ 6,308,000
Period of restrictions over awards 4 years    
Performance period 1 year    
Vesting period of Cliff from grant date 3 years    
Compensation expense | $ $ 4,033,000 3,319,000 3,323,000
Tax benefit recognized related to all awards | $ $ 1,533,000 $ 1,261,000 $ 1,263,000
Stock-Settled Appreciation Rights [Member]      
Shares or Units and Rights [Roll Forward]      
Outstanding, beginning balance (in shares) 129,975 149,700 121,749
Granted (in shares) 0 0 112,000
Exercised or restrictions lapsed (in shares) [1] (29,100) (13,725) (84,049)
Forfeited or expired (in shares) 0 (6,000) 0
Outstanding, ending balance (in shares) 100,875 129,975 149,700
Exercisable, ending balance (in shares) 48,875 51,975 37,700
Weighted-Average Award Price [Roll Forward]      
Outstanding, beginning balance (in dollars per share) | $ / shares $ 16.04 $ 15.78 $ 8.85
Granted (in dollars per share) | $ / shares 0 0 18.14
Exercised or restrictions lapsed (in dollars per share) | $ / shares [1] 8.74 12.30 8.90
Forfeited or expired (in dollars per share) | $ / shares   18.14 0
Outstanding, ending balance (in dollars per share) | $ / shares 18.14 16.04 15.78
Exercisable, ending balance (in dollars per share) | $ / shares $ 18.14 $ 12.88 $ 8.76
Weighted-Average Exercise Price [Roll Forward]      
Aggregate intrinsic value of vested awards | $ $ 161,000    
Aggregate intrinsic value of outstanding awards | $ $ 333,000    
Options [Member]      
Shares [Roll Forward]      
Outstanding, beginning balance (in shares) 0 0 50,000
Granted (in shares)     0
Exercised or restrictions lapsed (in shares) [1]     (48,000)
Forfeited or expired (in shares)     (2,000)
Outstanding, ending balance (in shares) 0 0 0
Exercisable, ending balance (in share)   0 0
Weighted-Average Exercise Price [Roll Forward]      
Outstanding, beginning balance (in dollars per share) | $ / shares $ 0 $ 0 $ 20.56
Granted (in dollars per share) | $ / shares     0
Exercised or restrictions lapsed (in dollars per share) | $ / shares [1]     20.75
Forfeited or expired (in dollars per share) | $ / shares     15.90
Outstanding, ending balance (in dollars per share) | $ / shares $ 0 0 0
Exercisable, ending balance (in dollars per share) | $ / shares   $ 0 $ 0
[1] The total intrinsic value of options and stock-settled appreciation rights exercised was approximately $457,000, $184,000 and $1,312,000 in 2015, 2014 and 2013, respectively.